We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$571M
AUM Growth
+$64.7M
(+13%)
Cap. Flow
+$77M
Cap. Flow
% of AUM
13.5%
Top 10 Holdings %
Top 10 Hldgs %
32.92%
Holding
757
New
120
Increased
159
Reduced
207
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$35.4M |
| 2 |
Stellantis
STLA
|
+$22.2M |
| 3 |
PepsiCo
PEP
|
+$18M |
| 4 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$6.64M |
| 5 |
Kohl's
KSS
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$21.5M |
| 2 |
iShares MSCI Indonesia ETF
EIDO
|
+$11.1M |
| 3 |
Eaton
ETN
|
+$4.76M |
| 4 |
Delta Air Lines
DAL
|
+$4.4M |
| 5 |
Western Union
WU
|
+$4.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.66% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Consumer Staples | 8.41% |
| 4 | Energy | 8.01% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Baker Hughes
BKR
$59.5B
| $103K | 0.02% |
4,198
-16,752
| -80% | -$404K |
|
327
Accenture
ACN
$99.9B
| $103K | 0.02% |
559
-927
| -62% | -$166K |
|
328
iShares US Real Estate ETF
IYR
$4.69B
| $103K | 0.02% |
1,178
-62
| -5% | -$5.43K |
|
|
XYZ
329
Block Inc
XYZ
$49.2B
| $103K | 0.02% |
+1,418
| New | +$99.1K |
|
330
Teleflex
TFX
$5.86B
| $102K | 0.02% |
308
| – | – |
|
331
LCI Industries
LCII
$2.5B
| $97.1K | 0.02% |
1,079
| – | – |
|
332
Abbott
ABT
$183B
| $96.7K | 0.02% |
+1,150
| New | +$90.5K |
|
333
Align Technology
ALGN
$12.4B
| $95.8K | 0.02% |
+350
| New | +$106K |
|
334
Hartford Financial Services
HIG
$39.2B
| $95.6K | 0.02% |
1,717
+83
| +5% | +$4.38K |
|
335
Stryker
SYK
$133B
| $94.9K | 0.02% |
462
| – | – |
|
336
Addus HomeCare
ADUS
$2.18B
| $94.7K | 0.02% |
+1,264
| New | +$87.3K |
|
|
CELG
337
DELISTED
Celgene Corp
CELG
| $93.6K | 0.02% |
1,013
-653
| -39% | -$62K |
|
338
Zebra Technologies
ZBRA
$13.7B
| $92.1K | 0.02% |
+440
| New | +$88.7K |
|
339
Marriott Vacations Worldwide
VAC
$3.35B
| $90.3K | 0.02% |
937
| – | – |
|
340
Royal Caribbean
RCL
$86.1B
| $89.1K | 0.02% |
735
| – | – |
|
341
Nokia
NOK
$50.7B
| $88.9K | 0.02% |
17,754
+508
| +3% | +$2.67K |
|
342
Norwegian Cruise Line
NCLH
$8.59B
| $87.4K | 0.02% |
1,630
-94
| -5% | -$5.22K |
|
343
Intuitive Surgical
ISRG
$126B
| $86K | 0.02% |
492
| – | – |
|
344
Acuity Brands
AYI
$10.1B
| $85.9K | 0.02% |
623
-773
| -55% | -$106K |
|
|
EPZM
345
DELISTED
Epizyme, Inc
EPZM
| $85.3K | 0.02% |
6,800
| – | – |
|
346
Crane NXT
CXT
$2.97B
| $83.4K | 0.01% |
+2,879
| New | +$83.8K |
|
|
WMGI
347
DELISTED
Wright Medical Group Inc
WMGI
| $82.8K | 0.01% |
2,777
| – | – |
|
348
Nu Skin
NUS
$254M
| $82.3K | 0.01% |
+1,670
| New | +$84.9K |
|
349
Infosys
INFY
$48.4B
| $82.3K | 0.01% |
7,691
+2,404
| +45% | +$25.5K |
|
350
Ligand Pharmaceuticals
LGND
$5.94B
| $82.2K | 0.01% |
1,154
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2019 Portfolio in Review
As of Q2 2019, Exane Derivatives held 757 positions worth $571M, up 13% from $506M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Exane Derivatives deployed $77M of net new capital in Q2 2019, opening 120 new positions and adding to 159 existing holdings. Its largest new stake was Stellantis: 1,528,258 shares worth $21.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 7.7% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was iShares MSCI Indonesia ETF, an estimated $11.1M trimmed.
- Exane Derivatives's largest Q2 2019 buy was Stellantis: 1,528,258 shares worth $21.6M.
- Exane Derivatives added most to UBS Group in Q2 2019, an estimated $35.4M increase.
- Exane Derivatives's biggest Q2 2019 reduction was iShares MSCI Indonesia ETF, cutting an estimated $11.1M.
- Exane Derivatives fully exited Linde in Q2 2019, selling an estimated $21.5M.
- Exane Derivatives's ten largest holdings make up 33% of its $571M portfolio in Q2 2019.
- Exane Derivatives opened 120 new positions and closed 89 in Q2 2019.
- Exane Derivatives's portfolio value rose 13% quarter-over-quarter to $571M.
Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.